Template:Anxiolytics - Revision history

Prab at 11:14, 26 March 2025

2025-03-26T11:14:46Z

← Older revision		Revision as of 11:14, 26 March 2025
Line 102:		Line 102:

	\| list9 = {{PharmNavFootnote}}		\| list9 = {{PharmNavFootnote}}




	}}<noinclude>		}}<noinclude>

Prab: 1 revision imported

2025-03-08T17:41:33Z

1 revision imported

← Older revision	Revision as of 17:41, 8 March 2025
(No difference)

en>Ahecht: Reduce WP:PEIS (transcluded on Alcohol (drug)) (via WP:JWB)

2024-05-08T13:51:53Z

Reduce WP:PEIS (transcluded on Alcohol (drug)) (via WP:JWB)

← Older revision		Revision as of 13:51, 8 May 2024
Line 1:		Line 1:
	{{~~Navbox~~		{{#invoke:navbox\|navbox
	\| name = Anxiolytics		\| name = Anxiolytics
	\| title = [[Anxiolytic]]s ([[ATC code N05#N05B\|N05B]])		\| title = [[Anxiolytic]]s ([[ATC code N05#N05B\|N05B]])
Line 9:		Line 9:
	\| list1 =		\| list1 =
	* [[Buspirone]]		* [[Buspirone]]
	* [[Gepirone]]~~<sup>†</sup>~~		* [[Gepirone]]
	* [[Tandospirone]]		* [[Tandospirone]]

Line 37:		Line 37:
	* [[Prazepam]]; ''Others:'' [[Alpidem]]<sup>‡</sup>		* [[Prazepam]]; ''Others:'' [[Alpidem]]<sup>‡</sup>
	* [[Barbiturate]]s (e.g., [[phenobarbital]])		* [[Barbiturate]]s (e.g., [[phenobarbital]])
			* [[Carbamate]]s (e.g., [[meprobamate]])
	* [[Carisoprodol]]		* [[Carisoprodol]]
	* [[Carbamate]]s (e.g., [[meprobamate]])
	* [[Chlormezanone]]<sup>‡</sup>		* [[Chlormezanone]]<sup>‡</sup>
	* [[Alcohol (drug)\|Ethanol (alcohol)]]		* [[Alcohol (drug)\|Ethanol (alcohol)]]
	* [[Etifoxine]]		* [[Etifoxine]]
	* [[Imepitoin]]; ''Herbs:''
	* [[Kava]]
	* [[Scutellaria\|Skullcap]]
	* [[Valerian (herb)\|Valerian]]

	\| group3 = [[Gabapentinoid]]s<br />~~{{Small\|~~([[Voltage-dependent calcium channel#.CE.B12.CE.B4_Subunit\|{{abbr\|α<sub>2</sub>δ\|alpha2delta subunit}} {{abbr\|VDCC\|voltage-dependent calcium channel}}]] [[channel blocker\|blocker]]s)}}		\| group3 = [[Hypnotic]]s
	\| ~~list3~~ =		\| list3 =
			* [[Zopiclone]]


			\| group4 = [[Gabapentinoid]]s<br /><span style="font-size:85%;">([[Voltage-dependent calcium channel#.CE.B12.CE.B4_Subunit\|{{abbr\|α<sub>2</sub>δ\|alpha2delta subunit}} {{abbr\|VDCC\|voltage-dependent calcium channel}}]] [[channel blocker\|blocker]]s)</span>
			\| list4 =
	* [[Gabapentin]]		* [[Gabapentin]]
	* [[Gabapentin enacarbil]]		* [[Gabapentin enacarbil]]
Line 54:		Line 55:
	* [[Pregabalin]]		* [[Pregabalin]]

	\| ~~group4~~ = [[Antidepressant]]s		\| group5 = [[Antidepressant]]s
	\| ~~list4~~ =		\| list5 =
	* {{abbrlink\|SSRIs\|Selective serotonin reuptake inhibitors}} (e.g., [[escitalopram]])		* {{abbrlink\|SSRIs\|Selective serotonin reuptake inhibitors}} (e.g., [[escitalopram]])
	* {{abbrlink\|SNRIs\|Serotonin-norepinephrine reuptake inhibitors}} (e.g., [[duloxetine]])		* {{abbrlink\|SNRIs\|Serotonin-norepinephrine reuptake inhibitors}} (e.g., [[duloxetine]])
Line 67:		Line 68:
	* [[Vortioxetine]]		* [[Vortioxetine]]

	\| ~~group5~~ = [[Sympatholytic]]s<br />~~{{Small\|~~([[Antiadrenergic]]s)}}		\| group6 = [[Antipsychotic]]s
	\| ~~list5~~ =		\| list6 =
			* [[Quetiapine]]
			* [[Flupentixol]]



			\| group7 = [[Sympatholytic]]s<br /><span style="font-size:85%;">([[Antiadrenergic]]s)</span>
			\| list7 =
	* [[Alpha-1 blocker]]s (e.g., [[prazosin]])		* [[Alpha-1 blocker]]s (e.g., [[prazosin]])
	* [[Alpha-2 agonist]]s (e.g., [[clonidine]], [[dexmedetomidine]], [[guanfacine]])		* [[Alpha-2 agonist]]s (e.g., [[clonidine]], [[dexmedetomidine]], [[guanfacine]])
	* [[Beta blocker]]s (e.g., [[propranolol]])		* [[Beta blocker]]s (e.g., [[propranolol]])

	\| ~~group6~~ = Others		\| group8 = Others
	\| ~~list6~~ =		\| list8 =
	* [[Benzoctamine]]		* [[Benzoctamine]]
	* [[Cannabidiol]]
	* [[Cycloserine]]		* [[Cycloserine]]
	* [[Fabomotizole]]		* [[Fabomotizole]]
	* [[Hydroxyzine]]		* [[Hydroxyzine]]
	* [[Sceletium tortuosum\|Kanna]]
	* [[Lavandula\|Lavender]]
	* [[Lorpiprazole]]		* [[Lorpiprazole]]
	* [[Mebicar]]		* [[Mebicar]]
Line 96:		Line 101:
	* [[Validolum]]		* [[Validolum]]

	\| ~~list7~~ = {{PharmNavFootnote}}		\| list9 = {{PharmNavFootnote}}




	}}		}}<noinclude>
	<noinclude>
	{{collapsible option}}		{{collapsible option}}
	[[Category:Drug_templates by ATC]]		[[Category:Drug_templates by ATC]]
	</noinclude>		</noinclude>
	~~{{no-index-template}}~~

Prab: CSV import

2024-04-30T03:22:02Z

CSV import

New page

{{Navbox
| name = Anxiolytics
| title = [[Anxiolytic]]s ([[ATC code N05#N05B|N05B]])
| state = {{{state<includeonly>|collapsed</includeonly>}}}
| groupstyle = text-align:center;
| listclass = hlist

| group1 = {{abbrlink|5-HT1AR|5-HT1A receptor}} [[agonist]]s
| list1 =
* [[Buspirone]]
* [[Gepirone]]†
* [[Tandospirone]]

| group2 = {{abbrlink|GABAAR|GABAA receptor}} {{abbrlink|PAMs|positive allosteric modulators}}
| list2 =
* ''[[Benzodiazepine]]s:'' [[Adinazolam]]
* [[Alprazolam]]
* [[Bromazepam]]
* [[Camazepam]]
* [[Chlordiazepoxide]]
* [[Clobazam]]
* [[Clonazepam]]
* [[Clorazepate]]
* [[Clotiazepam]]
* [[Cloxazolam]]
* [[Diazepam]]#
* [[Ethyl loflazepate]]
* [[Etizolam]]
* [[Fludiazepam]]
* [[Halazepam]]
* [[Ketazolam]]
* [[Lorazepam]]#
* [[Medazepam]]
* [[Nordazepam]]
* [[Oxazepam]]
* [[Pinazepam]]
* [[Prazepam]]; ''Others:'' [[Alpidem]]‡
* [[Barbiturate]]s (e.g., [[phenobarbital]])
* [[Carisoprodol]]
* [[Carbamate]]s (e.g., [[meprobamate]])
* [[Chlormezanone]]‡
* [[Alcohol (drug)|Ethanol (alcohol)]]
* [[Etifoxine]]
* [[Imepitoin]]; ''Herbs:''
* [[Kava]]
* [[Scutellaria|Skullcap]]
* [[Valerian (herb)|Valerian]]

| group3 = [[Gabapentinoid]]s {{Small|([[Voltage-dependent calcium channel#.CE.B12.CE.B4_Subunit|{{abbr|α2δ|alpha2delta subunit}} {{abbr|VDCC|voltage-dependent calcium channel}}]] [[channel blocker|blocker]]s)}}
| list3 =
* [[Gabapentin]]
* [[Gabapentin enacarbil]]
* [[Phenibut]]
* [[Pregabalin]]

| group4 = [[Antidepressant]]s
| list4 =
* {{abbrlink|SSRIs|Selective serotonin reuptake inhibitors}} (e.g., [[escitalopram]])
* {{abbrlink|SNRIs|Serotonin-norepinephrine reuptake inhibitors}} (e.g., [[duloxetine]])
* {{abbrlink|SARIs|Serotonin antagonist and reuptake inhibitors}} (e.g., [[trazodone]])
* {{abbrlink|TCAs|Tricyclic antidepressants}} (e.g., [[clomipramine]]#)
* {{abbrlink|TeCAs|Tetracyclic antidepressants}} (e.g., [[mirtazapine]])
* {{abbrlink|MAOIs|Monoamine oxidase inhibitors}} (e.g., [[phenelzine]]); ''Others:'' [[Agomelatine]]
* [[Bupropion]]
* [[Tianeptine]]
* [[Vilazodone]]
* [[Vortioxetine]]

| group5 = [[Sympatholytic]]s {{Small|([[Antiadrenergic]]s)}}
| list5 =
* [[Alpha-1 blocker]]s (e.g., [[prazosin]])
* [[Alpha-2 agonist]]s (e.g., [[clonidine]], [[dexmedetomidine]], [[guanfacine]])
* [[Beta blocker]]s (e.g., [[propranolol]])

| group6 = Others
| list6 =
* [[Benzoctamine]]
* [[Cannabidiol]]
* [[Cycloserine]]
* [[Fabomotizole]]
* [[Hydroxyzine]]
* [[Sceletium tortuosum|Kanna]]
* [[Lavandula|Lavender]]
* [[Lorpiprazole]]
* [[Mebicar]]
* [[Mepiprazole]]
* [[Nicotine]]
* [[Opipramol]]
* [[Oxaflozane]]‡
* [[Phenaglycodol]]
* [[Phenibut]]
* [[Picamilon]]
* [[Selank]]
* [[Tiagabine]]
* [[Tofisopam]]
* [[Validolum]]

| list7 = {{PharmNavFootnote}}

}}
<noinclude>
{{collapsible option}}
[[Category:Drug_templates by ATC]]
</noinclude>
{{no-index-template}}